nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—melanoma	0.318	0.736	CbGaD
Telmisartan—ABCB1—melanoma	0.114	0.264	CbGaD
Telmisartan—ABCG2—Vemurafenib—melanoma	0.103	0.286	CbGbCtD
Telmisartan—SLCO1B3—Docetaxel—melanoma	0.0762	0.212	CbGbCtD
Telmisartan—ABCG2—Dactinomycin—melanoma	0.0683	0.19	CbGbCtD
Telmisartan—ABCC2—Docetaxel—melanoma	0.039	0.109	CbGbCtD
Telmisartan—ABCG2—Docetaxel—melanoma	0.0353	0.0983	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—melanoma	0.0246	0.0686	CbGbCtD
Telmisartan—ABCB1—Docetaxel—melanoma	0.0127	0.0354	CbGbCtD
Telmisartan—PPARG—dermis—melanoma	0.0059	0.183	CbGeAlD
Telmisartan—PPARG—leg—melanoma	0.00389	0.121	CbGeAlD
Telmisartan—PPARG—hindlimb—melanoma	0.00348	0.108	CbGeAlD
Telmisartan—PPARG—appendage—melanoma	0.00298	0.0927	CbGeAlD
Telmisartan—AGTR1—endothelium—melanoma	0.00219	0.068	CbGeAlD
Telmisartan—AGTR1—blood vessel—melanoma	0.00202	0.0627	CbGeAlD
Telmisartan—PPARG—endothelium—melanoma	0.0018	0.0559	CbGeAlD
Telmisartan—PPARG—blood vessel—melanoma	0.00166	0.0516	CbGeAlD
Telmisartan—AGTR1—neck—melanoma	0.00144	0.0449	CbGeAlD
Telmisartan—PPARG—neck—melanoma	0.00119	0.0369	CbGeAlD
Telmisartan—PPARG—skin of body—melanoma	0.000769	0.0239	CbGeAlD
Telmisartan—PPARG—mammalian vulva—melanoma	0.000701	0.0218	CbGeAlD
Telmisartan—AGTR1—head—melanoma	0.00061	0.0189	CbGeAlD
Telmisartan—ABCB1—blood vessel—melanoma	0.000525	0.0163	CbGeAlD
Telmisartan—PPARG—head—melanoma	0.000501	0.0156	CbGeAlD
Telmisartan—ABCG2—mammalian vulva—melanoma	0.000449	0.014	CbGeAlD
Telmisartan—AGTR1—lymph node—melanoma	0.000427	0.0133	CbGeAlD
Telmisartan—PPARG—lymph node—melanoma	0.000351	0.0109	CbGeAlD
Telmisartan—ABCC2—lymph node—melanoma	0.000309	0.00959	CbGeAlD
Telmisartan—ABCB1—retina—melanoma	0.000277	0.0086	CbGeAlD
Telmisartan—Pruritus—Vemurafenib—melanoma	0.000247	0.00244	CcSEcCtD
Telmisartan—Connective tissue disorder—Temozolomide—melanoma	0.000247	0.00243	CcSEcCtD
Telmisartan—Urethral disorder—Temozolomide—melanoma	0.000246	0.00243	CcSEcCtD
Telmisartan—Eye disorder—Carmustine—melanoma	0.000243	0.0024	CcSEcCtD
Telmisartan—Visual impairment—Temozolomide—melanoma	0.000242	0.00239	CcSEcCtD
Telmisartan—Erythema—Dactinomycin—melanoma	0.000242	0.00238	CcSEcCtD
Telmisartan—Pain in extremity—Docetaxel—melanoma	0.000242	0.00238	CcSEcCtD
Telmisartan—Flushing—Carmustine—melanoma	0.000241	0.00238	CcSEcCtD
Telmisartan—Ill-defined disorder—Bleomycin—melanoma	0.000241	0.00237	CcSEcCtD
Telmisartan—Anaemia—Bleomycin—melanoma	0.00024	0.00236	CcSEcCtD
Telmisartan—Diarrhoea—Vemurafenib—melanoma	0.000239	0.00236	CcSEcCtD
Telmisartan—Migraine—Docetaxel—melanoma	0.000238	0.00234	CcSEcCtD
Telmisartan—Eye disorder—Temozolomide—melanoma	0.000235	0.00232	CcSEcCtD
Telmisartan—Tinnitus—Temozolomide—melanoma	0.000234	0.00231	CcSEcCtD
Telmisartan—Malaise—Bleomycin—melanoma	0.000234	0.00231	CcSEcCtD
Telmisartan—Flushing—Temozolomide—melanoma	0.000233	0.0023	CcSEcCtD
Telmisartan—Cardiac disorder—Temozolomide—melanoma	0.000233	0.0023	CcSEcCtD
Telmisartan—Arrhythmia—Carmustine—melanoma	0.000232	0.00229	CcSEcCtD
Telmisartan—Dizziness—Vemurafenib—melanoma	0.000231	0.00228	CcSEcCtD
Telmisartan—Angiopathy—Temozolomide—melanoma	0.000228	0.00225	CcSEcCtD
Telmisartan—Mental disorder—Carmustine—melanoma	0.000228	0.00225	CcSEcCtD
Telmisartan—Immune system disorder—Temozolomide—melanoma	0.000227	0.00224	CcSEcCtD
Telmisartan—Mediastinal disorder—Temozolomide—melanoma	0.000227	0.00223	CcSEcCtD
Telmisartan—Malnutrition—Carmustine—melanoma	0.000227	0.00223	CcSEcCtD
Telmisartan—Erythema—Carmustine—melanoma	0.000227	0.00223	CcSEcCtD
Telmisartan—Cough—Bleomycin—melanoma	0.000226	0.00223	CcSEcCtD
Telmisartan—Chills—Temozolomide—melanoma	0.000226	0.00222	CcSEcCtD
Telmisartan—ABCG2—lymph node—melanoma	0.000225	0.00699	CbGeAlD
Telmisartan—Ill-defined disorder—Dactinomycin—melanoma	0.000225	0.00221	CcSEcCtD
Telmisartan—Anaemia—Dactinomycin—melanoma	0.000224	0.0022	CcSEcCtD
Telmisartan—Vomiting—Vemurafenib—melanoma	0.000222	0.00219	CcSEcCtD
Telmisartan—Dry skin—Docetaxel—melanoma	0.000222	0.00218	CcSEcCtD
Telmisartan—ABCB1—mammalian vulva—melanoma	0.000222	0.00688	CbGeAlD
Telmisartan—Chest pain—Bleomycin—melanoma	0.000221	0.00218	CcSEcCtD
Telmisartan—Myalgia—Bleomycin—melanoma	0.000221	0.00218	CcSEcCtD
Telmisartan—Orthostatic hypotension—Docetaxel—melanoma	0.000221	0.00218	CcSEcCtD
Telmisartan—Rash—Vemurafenib—melanoma	0.00022	0.00217	CcSEcCtD
Telmisartan—Mental disorder—Temozolomide—melanoma	0.00022	0.00217	CcSEcCtD
Telmisartan—Dermatitis—Vemurafenib—melanoma	0.00022	0.00217	CcSEcCtD
Telmisartan—Back pain—Carmustine—melanoma	0.000219	0.00216	CcSEcCtD
Telmisartan—Headache—Vemurafenib—melanoma	0.000219	0.00216	CcSEcCtD
Telmisartan—Malnutrition—Temozolomide—melanoma	0.000219	0.00216	CcSEcCtD
Telmisartan—Erythema—Temozolomide—melanoma	0.000219	0.00216	CcSEcCtD
Telmisartan—Breast disorder—Docetaxel—melanoma	0.000218	0.00215	CcSEcCtD
Telmisartan—Discomfort—Bleomycin—melanoma	0.000218	0.00215	CcSEcCtD
Telmisartan—Malaise—Dactinomycin—melanoma	0.000218	0.00215	CcSEcCtD
Telmisartan—Cramp muscle—Docetaxel—melanoma	0.000218	0.00214	CcSEcCtD
Telmisartan—Dysgeusia—Temozolomide—melanoma	0.000214	0.00211	CcSEcCtD
Telmisartan—Oedema—Bleomycin—melanoma	0.000212	0.00209	CcSEcCtD
Telmisartan—Anaphylactic shock—Bleomycin—melanoma	0.000212	0.00209	CcSEcCtD
Telmisartan—Back pain—Temozolomide—melanoma	0.000212	0.00209	CcSEcCtD
Telmisartan—Infection—Bleomycin—melanoma	0.00021	0.00207	CcSEcCtD
Telmisartan—Anaemia—Carmustine—melanoma	0.000209	0.00206	CcSEcCtD
Telmisartan—Nausea—Vemurafenib—melanoma	0.000208	0.00205	CcSEcCtD
Telmisartan—Thrombocytopenia—Bleomycin—melanoma	0.000207	0.00204	CcSEcCtD
Telmisartan—Myalgia—Dactinomycin—melanoma	0.000206	0.00203	CcSEcCtD
Telmisartan—Bronchospasm—Docetaxel—melanoma	0.000205	0.00202	CcSEcCtD
Telmisartan—Discomfort—Dactinomycin—melanoma	0.000204	0.00201	CcSEcCtD
Telmisartan—Angina pectoris—Docetaxel—melanoma	0.000204	0.00201	CcSEcCtD
Telmisartan—Ill-defined disorder—Temozolomide—melanoma	0.000203	0.002	CcSEcCtD
Telmisartan—Anaemia—Temozolomide—melanoma	0.000202	0.00199	CcSEcCtD
Telmisartan—Anorexia—Bleomycin—melanoma	0.000202	0.00199	CcSEcCtD
Telmisartan—Angioedema—Temozolomide—melanoma	0.0002	0.00197	CcSEcCtD
Telmisartan—Hypotension—Bleomycin—melanoma	0.000198	0.00195	CcSEcCtD
Telmisartan—Oedema—Dactinomycin—melanoma	0.000198	0.00195	CcSEcCtD
Telmisartan—Malaise—Temozolomide—melanoma	0.000197	0.00194	CcSEcCtD
Telmisartan—Vertigo—Temozolomide—melanoma	0.000197	0.00194	CcSEcCtD
Telmisartan—Infection—Dactinomycin—melanoma	0.000196	0.00193	CcSEcCtD
Telmisartan—Hypertension—Carmustine—melanoma	0.000196	0.00193	CcSEcCtD
Telmisartan—Palpitations—Temozolomide—melanoma	0.000193	0.00191	CcSEcCtD
Telmisartan—Thrombocytopenia—Dactinomycin—melanoma	0.000193	0.00191	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Bleomycin—melanoma	0.000193	0.0019	CcSEcCtD
Telmisartan—Myalgia—Carmustine—melanoma	0.000193	0.0019	CcSEcCtD
Telmisartan—Chest pain—Carmustine—melanoma	0.000193	0.0019	CcSEcCtD
Telmisartan—Anxiety—Carmustine—melanoma	0.000192	0.00189	CcSEcCtD
Telmisartan—Cough—Temozolomide—melanoma	0.000191	0.00188	CcSEcCtD
Telmisartan—Paraesthesia—Bleomycin—melanoma	0.00019	0.00187	CcSEcCtD
Telmisartan—Hypertension—Temozolomide—melanoma	0.000189	0.00186	CcSEcCtD
Telmisartan—Dyspnoea—Bleomycin—melanoma	0.000189	0.00186	CcSEcCtD
Telmisartan—Anorexia—Dactinomycin—melanoma	0.000188	0.00186	CcSEcCtD
Telmisartan—Pneumonia—Docetaxel—melanoma	0.000187	0.00185	CcSEcCtD
Telmisartan—Arthralgia—Temozolomide—melanoma	0.000186	0.00184	CcSEcCtD
Telmisartan—Myalgia—Temozolomide—melanoma	0.000186	0.00184	CcSEcCtD
Telmisartan—Infestation—Docetaxel—melanoma	0.000186	0.00184	CcSEcCtD
Telmisartan—Infestation NOS—Docetaxel—melanoma	0.000186	0.00184	CcSEcCtD
Telmisartan—Anxiety—Temozolomide—melanoma	0.000186	0.00183	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000185	0.00182	CcSEcCtD
Telmisartan—Oedema—Carmustine—melanoma	0.000185	0.00182	CcSEcCtD
Telmisartan—Discomfort—Temozolomide—melanoma	0.000184	0.00181	CcSEcCtD
Telmisartan—Decreased appetite—Bleomycin—melanoma	0.000184	0.00181	CcSEcCtD
Telmisartan—Infection—Carmustine—melanoma	0.000184	0.00181	CcSEcCtD
Telmisartan—Acute coronary syndrome—Docetaxel—melanoma	0.000184	0.00181	CcSEcCtD
Telmisartan—Renal failure—Docetaxel—melanoma	0.000183	0.0018	CcSEcCtD
Telmisartan—Myocardial infarction—Docetaxel—melanoma	0.000183	0.0018	CcSEcCtD
Telmisartan—Neuropathy peripheral—Docetaxel—melanoma	0.000183	0.0018	CcSEcCtD
Telmisartan—Dry mouth—Temozolomide—melanoma	0.000182	0.0018	CcSEcCtD
Telmisartan—Pain—Bleomycin—melanoma	0.000181	0.00178	CcSEcCtD
Telmisartan—Conjunctivitis—Docetaxel—melanoma	0.000181	0.00178	CcSEcCtD
Telmisartan—Thrombocytopenia—Carmustine—melanoma	0.000181	0.00178	CcSEcCtD
Telmisartan—Tachycardia—Carmustine—melanoma	0.00018	0.00178	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00018	0.00177	CcSEcCtD
Telmisartan—Oedema—Temozolomide—melanoma	0.000179	0.00176	CcSEcCtD
Telmisartan—Anaphylactic shock—Temozolomide—melanoma	0.000179	0.00176	CcSEcCtD
Telmisartan—Infection—Temozolomide—melanoma	0.000177	0.00175	CcSEcCtD
Telmisartan—Anorexia—Carmustine—melanoma	0.000176	0.00174	CcSEcCtD
Telmisartan—Hepatobiliary disease—Docetaxel—melanoma	0.000176	0.00174	CcSEcCtD
Telmisartan—Epistaxis—Docetaxel—melanoma	0.000176	0.00173	CcSEcCtD
Telmisartan—Nervous system disorder—Temozolomide—melanoma	0.000175	0.00173	CcSEcCtD
Telmisartan—Thrombocytopenia—Temozolomide—melanoma	0.000175	0.00172	CcSEcCtD
Telmisartan—Feeling abnormal—Bleomycin—melanoma	0.000175	0.00172	CcSEcCtD
Telmisartan—Skin disorder—Temozolomide—melanoma	0.000174	0.00171	CcSEcCtD
Telmisartan—Hypotension—Carmustine—melanoma	0.000173	0.0017	CcSEcCtD
Telmisartan—Hyperhidrosis—Temozolomide—melanoma	0.000173	0.0017	CcSEcCtD
Telmisartan—Decreased appetite—Dactinomycin—melanoma	0.000172	0.00169	CcSEcCtD
Telmisartan—Fatigue—Dactinomycin—melanoma	0.00017	0.00168	CcSEcCtD
Telmisartan—Anorexia—Temozolomide—melanoma	0.00017	0.00168	CcSEcCtD
Telmisartan—Pain—Dactinomycin—melanoma	0.000169	0.00166	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Carmustine—melanoma	0.000168	0.00166	CcSEcCtD
Telmisartan—Urticaria—Bleomycin—melanoma	0.000168	0.00166	CcSEcCtD
Telmisartan—Rhinitis—Docetaxel—melanoma	0.000168	0.00165	CcSEcCtD
Telmisartan—Body temperature increased—Bleomycin—melanoma	0.000167	0.00165	CcSEcCtD
Telmisartan—Insomnia—Carmustine—melanoma	0.000167	0.00165	CcSEcCtD
Telmisartan—Hypoaesthesia—Docetaxel—melanoma	0.000166	0.00164	CcSEcCtD
Telmisartan—Paraesthesia—Carmustine—melanoma	0.000166	0.00164	CcSEcCtD
Telmisartan—Pharyngitis—Docetaxel—melanoma	0.000166	0.00164	CcSEcCtD
Telmisartan—Urinary tract disorder—Docetaxel—melanoma	0.000165	0.00163	CcSEcCtD
Telmisartan—Dyspnoea—Carmustine—melanoma	0.000165	0.00162	CcSEcCtD
Telmisartan—Oedema peripheral—Docetaxel—melanoma	0.000165	0.00162	CcSEcCtD
Telmisartan—Somnolence—Carmustine—melanoma	0.000164	0.00162	CcSEcCtD
Telmisartan—Connective tissue disorder—Docetaxel—melanoma	0.000164	0.00162	CcSEcCtD
Telmisartan—Urethral disorder—Docetaxel—melanoma	0.000164	0.00162	CcSEcCtD
Telmisartan—Feeling abnormal—Dactinomycin—melanoma	0.000163	0.0016	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000163	0.0016	CcSEcCtD
Telmisartan—Insomnia—Temozolomide—melanoma	0.000162	0.00159	CcSEcCtD
Telmisartan—Gastrointestinal pain—Dactinomycin—melanoma	0.000162	0.00159	CcSEcCtD
Telmisartan—Visual impairment—Docetaxel—melanoma	0.000161	0.00159	CcSEcCtD
Telmisartan—Decreased appetite—Carmustine—melanoma	0.000161	0.00158	CcSEcCtD
Telmisartan—Paraesthesia—Temozolomide—melanoma	0.00016	0.00158	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Carmustine—melanoma	0.00016	0.00157	CcSEcCtD
Telmisartan—Dyspnoea—Temozolomide—melanoma	0.000159	0.00157	CcSEcCtD
Telmisartan—Somnolence—Temozolomide—melanoma	0.000159	0.00156	CcSEcCtD
Telmisartan—ABCB1—head—melanoma	0.000159	0.00492	CbGeAlD
Telmisartan—Pain—Carmustine—melanoma	0.000158	0.00156	CcSEcCtD
Telmisartan—Constipation—Carmustine—melanoma	0.000158	0.00156	CcSEcCtD
Telmisartan—Dyspepsia—Temozolomide—melanoma	0.000157	0.00155	CcSEcCtD
Telmisartan—Eye disorder—Docetaxel—melanoma	0.000156	0.00154	CcSEcCtD
Telmisartan—Body temperature increased—Dactinomycin—melanoma	0.000156	0.00154	CcSEcCtD
Telmisartan—Abdominal pain—Dactinomycin—melanoma	0.000156	0.00154	CcSEcCtD
Telmisartan—Hypersensitivity—Bleomycin—melanoma	0.000156	0.00154	CcSEcCtD
Telmisartan—Decreased appetite—Temozolomide—melanoma	0.000155	0.00153	CcSEcCtD
Telmisartan—Flushing—Docetaxel—melanoma	0.000155	0.00153	CcSEcCtD
Telmisartan—Cardiac disorder—Docetaxel—melanoma	0.000155	0.00153	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Temozolomide—melanoma	0.000154	0.00152	CcSEcCtD
Telmisartan—Fatigue—Temozolomide—melanoma	0.000154	0.00152	CcSEcCtD
Telmisartan—Constipation—Temozolomide—melanoma	0.000153	0.00151	CcSEcCtD
Telmisartan—Pain—Temozolomide—melanoma	0.000153	0.00151	CcSEcCtD
Telmisartan—Feeling abnormal—Carmustine—melanoma	0.000152	0.0015	CcSEcCtD
Telmisartan—Asthenia—Bleomycin—melanoma	0.000152	0.0015	CcSEcCtD
Telmisartan—Angiopathy—Docetaxel—melanoma	0.000152	0.00149	CcSEcCtD
Telmisartan—Gastrointestinal pain—Carmustine—melanoma	0.000151	0.00149	CcSEcCtD
Telmisartan—Immune system disorder—Docetaxel—melanoma	0.000151	0.00149	CcSEcCtD
Telmisartan—Mediastinal disorder—Docetaxel—melanoma	0.000151	0.00148	CcSEcCtD
Telmisartan—Chills—Docetaxel—melanoma	0.00015	0.00148	CcSEcCtD
Telmisartan—Pruritus—Bleomycin—melanoma	0.00015	0.00148	CcSEcCtD
Telmisartan—Arrhythmia—Docetaxel—melanoma	0.000149	0.00147	CcSEcCtD
Telmisartan—Feeling abnormal—Temozolomide—melanoma	0.000147	0.00145	CcSEcCtD
Telmisartan—Mental disorder—Docetaxel—melanoma	0.000146	0.00144	CcSEcCtD
Telmisartan—Body temperature increased—Carmustine—melanoma	0.000146	0.00144	CcSEcCtD
Telmisartan—Abdominal pain—Carmustine—melanoma	0.000146	0.00144	CcSEcCtD
Telmisartan—Gastrointestinal pain—Temozolomide—melanoma	0.000146	0.00144	CcSEcCtD
Telmisartan—Malnutrition—Docetaxel—melanoma	0.000146	0.00143	CcSEcCtD
Telmisartan—Erythema—Docetaxel—melanoma	0.000146	0.00143	CcSEcCtD
Telmisartan—Hypersensitivity—Dactinomycin—melanoma	0.000146	0.00143	CcSEcCtD
Telmisartan—Dysgeusia—Docetaxel—melanoma	0.000143	0.0014	CcSEcCtD
Telmisartan—Urticaria—Temozolomide—melanoma	0.000142	0.0014	CcSEcCtD
Telmisartan—Asthenia—Dactinomycin—melanoma	0.000142	0.0014	CcSEcCtD
Telmisartan—Abdominal pain—Temozolomide—melanoma	0.000141	0.00139	CcSEcCtD
Telmisartan—Body temperature increased—Temozolomide—melanoma	0.000141	0.00139	CcSEcCtD
Telmisartan—Back pain—Docetaxel—melanoma	0.000141	0.00139	CcSEcCtD
Telmisartan—Muscle spasms—Docetaxel—melanoma	0.00014	0.00138	CcSEcCtD
Telmisartan—Hypersensitivity—Carmustine—melanoma	0.000136	0.00134	CcSEcCtD
Telmisartan—Diarrhoea—Dactinomycin—melanoma	0.000135	0.00133	CcSEcCtD
Telmisartan—Vomiting—Bleomycin—melanoma	0.000135	0.00133	CcSEcCtD
Telmisartan—Anaemia—Docetaxel—melanoma	0.000135	0.00133	CcSEcCtD
Telmisartan—Rash—Bleomycin—melanoma	0.000134	0.00132	CcSEcCtD
Telmisartan—Dermatitis—Bleomycin—melanoma	0.000133	0.00131	CcSEcCtD
Telmisartan—Asthenia—Carmustine—melanoma	0.000133	0.00131	CcSEcCtD
Telmisartan—Hypersensitivity—Temozolomide—melanoma	0.000132	0.0013	CcSEcCtD
Telmisartan—Syncope—Docetaxel—melanoma	0.000131	0.00129	CcSEcCtD
Telmisartan—Palpitations—Docetaxel—melanoma	0.000129	0.00127	CcSEcCtD
Telmisartan—Asthenia—Temozolomide—melanoma	0.000128	0.00126	CcSEcCtD
Telmisartan—Loss of consciousness—Docetaxel—melanoma	0.000128	0.00126	CcSEcCtD
Telmisartan—Cough—Docetaxel—melanoma	0.000127	0.00125	CcSEcCtD
Telmisartan—Diarrhoea—Carmustine—melanoma	0.000126	0.00125	CcSEcCtD
Telmisartan—Pruritus—Temozolomide—melanoma	0.000126	0.00125	CcSEcCtD
Telmisartan—Nausea—Bleomycin—melanoma	0.000126	0.00124	CcSEcCtD
Telmisartan—Hypertension—Docetaxel—melanoma	0.000126	0.00124	CcSEcCtD
Telmisartan—Vomiting—Dactinomycin—melanoma	0.000126	0.00124	CcSEcCtD
Telmisartan—Rash—Dactinomycin—melanoma	0.000125	0.00123	CcSEcCtD
Telmisartan—Myalgia—Docetaxel—melanoma	0.000124	0.00122	CcSEcCtD
Telmisartan—Arthralgia—Docetaxel—melanoma	0.000124	0.00122	CcSEcCtD
Telmisartan—Chest pain—Docetaxel—melanoma	0.000124	0.00122	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000123	0.00121	CcSEcCtD
Telmisartan—Dizziness—Carmustine—melanoma	0.000122	0.0012	CcSEcCtD
Telmisartan—Diarrhoea—Temozolomide—melanoma	0.000122	0.0012	CcSEcCtD
Telmisartan—Dry mouth—Docetaxel—melanoma	0.000121	0.00119	CcSEcCtD
Telmisartan—Anaphylactic shock—Docetaxel—melanoma	0.000119	0.00117	CcSEcCtD
Telmisartan—Oedema—Docetaxel—melanoma	0.000119	0.00117	CcSEcCtD
Telmisartan—Dizziness—Temozolomide—melanoma	0.000118	0.00116	CcSEcCtD
Telmisartan—Infection—Docetaxel—melanoma	0.000118	0.00116	CcSEcCtD
Telmisartan—Vomiting—Carmustine—melanoma	0.000118	0.00116	CcSEcCtD
Telmisartan—Nausea—Dactinomycin—melanoma	0.000117	0.00116	CcSEcCtD
Telmisartan—Shock—Docetaxel—melanoma	0.000117	0.00115	CcSEcCtD
Telmisartan—Rash—Carmustine—melanoma	0.000117	0.00115	CcSEcCtD
Telmisartan—Nervous system disorder—Docetaxel—melanoma	0.000117	0.00115	CcSEcCtD
Telmisartan—Dermatitis—Carmustine—melanoma	0.000116	0.00115	CcSEcCtD
Telmisartan—Thrombocytopenia—Docetaxel—melanoma	0.000116	0.00115	CcSEcCtD
Telmisartan—Tachycardia—Docetaxel—melanoma	0.000116	0.00114	CcSEcCtD
Telmisartan—Headache—Carmustine—melanoma	0.000116	0.00114	CcSEcCtD
Telmisartan—Skin disorder—Docetaxel—melanoma	0.000115	0.00114	CcSEcCtD
Telmisartan—Vomiting—Temozolomide—melanoma	0.000114	0.00112	CcSEcCtD
Telmisartan—Anorexia—Docetaxel—melanoma	0.000113	0.00112	CcSEcCtD
Telmisartan—Rash—Temozolomide—melanoma	0.000113	0.00111	CcSEcCtD
Telmisartan—Dermatitis—Temozolomide—melanoma	0.000113	0.00111	CcSEcCtD
Telmisartan—Headache—Temozolomide—melanoma	0.000112	0.0011	CcSEcCtD
Telmisartan—Hypotension—Docetaxel—melanoma	0.000111	0.00109	CcSEcCtD
Telmisartan—ABCB1—lymph node—melanoma	0.000111	0.00345	CbGeAlD
Telmisartan—Nausea—Carmustine—melanoma	0.00011	0.00108	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000108	0.00107	CcSEcCtD
Telmisartan—Insomnia—Docetaxel—melanoma	0.000107	0.00106	CcSEcCtD
Telmisartan—Paraesthesia—Docetaxel—melanoma	0.000107	0.00105	CcSEcCtD
Telmisartan—Nausea—Temozolomide—melanoma	0.000106	0.00105	CcSEcCtD
Telmisartan—Dyspnoea—Docetaxel—melanoma	0.000106	0.00104	CcSEcCtD
Telmisartan—Somnolence—Docetaxel—melanoma	0.000106	0.00104	CcSEcCtD
Telmisartan—Dyspepsia—Docetaxel—melanoma	0.000105	0.00103	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—melanoma	0.000103	0.00102	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—melanoma	0.000103	0.00101	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—melanoma	0.000102	0.00101	CcSEcCtD
Telmisartan—Pain—Docetaxel—melanoma	0.000102	0.001	CcSEcCtD
Telmisartan—Constipation—Docetaxel—melanoma	0.000102	0.001	CcSEcCtD
Telmisartan—Feeling abnormal—Docetaxel—melanoma	9.79e-05	0.000965	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—melanoma	9.71e-05	0.000957	CcSEcCtD
Telmisartan—Abdominal pain—Docetaxel—melanoma	9.39e-05	0.000925	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—melanoma	9.39e-05	0.000925	CcSEcCtD
Telmisartan—Hypersensitivity—Docetaxel—melanoma	8.75e-05	0.000862	CcSEcCtD
Telmisartan—Asthenia—Docetaxel—melanoma	8.52e-05	0.00084	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—melanoma	8.41e-05	0.000828	CcSEcCtD
Telmisartan—Diarrhoea—Docetaxel—melanoma	8.13e-05	0.000801	CcSEcCtD
Telmisartan—Dizziness—Docetaxel—melanoma	7.86e-05	0.000774	CcSEcCtD
Telmisartan—Vomiting—Docetaxel—melanoma	7.55e-05	0.000744	CcSEcCtD
Telmisartan—Rash—Docetaxel—melanoma	7.49e-05	0.000738	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—melanoma	7.48e-05	0.000737	CcSEcCtD
Telmisartan—Headache—Docetaxel—melanoma	7.44e-05	0.000733	CcSEcCtD
Telmisartan—Nausea—Docetaxel—melanoma	7.06e-05	0.000695	CcSEcCtD
Telmisartan—Candesartan—ABCB1—melanoma	2.38e-05	0.431	CrCbGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.7e-05	0.000224	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—VDR—melanoma	1.69e-05	0.000224	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CD44—melanoma	1.67e-05	0.000221	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GNAQ—melanoma	1.67e-05	0.000221	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.66e-05	0.000219	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—VCAN—melanoma	1.64e-05	0.000217	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.64e-05	0.000216	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLCB4—melanoma	1.62e-05	0.000215	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—melanoma	1.62e-05	0.000214	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.62e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.61e-05	0.000213	CbGpPWpGaD
Telmisartan—Losartan—ALB—melanoma	1.61e-05	0.291	CrCbGaD
Telmisartan—AGTR1—Signaling Pathways—SOCS1—melanoma	1.6e-05	0.000212	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1B1—melanoma	1.6e-05	0.000212	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAP2K1—melanoma	1.6e-05	0.000211	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—S100B—melanoma	1.6e-05	0.000211	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	1.59e-05	0.000211	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—melanoma	1.59e-05	0.00021	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CD—melanoma	1.59e-05	0.00021	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.59e-05	0.00021	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLCB4—melanoma	1.59e-05	0.000209	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NFKB1—melanoma	1.57e-05	0.000208	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.56e-05	0.000207	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PRKCA—melanoma	1.56e-05	0.000206	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ERCC2—melanoma	1.55e-05	0.000204	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—melanoma	1.55e-05	0.000204	CbGpPWpGaD
Telmisartan—Losartan—ABCB1—melanoma	1.54e-05	0.278	CrCbGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.53e-05	0.000202	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB4—melanoma	1.53e-05	0.000202	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIP4K2A—melanoma	1.53e-05	0.000202	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC6A11—melanoma	1.53e-05	0.000202	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CB—melanoma	1.52e-05	0.000201	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN2B—melanoma	1.52e-05	0.0002	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC6A11—melanoma	1.49e-05	0.000197	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIP4K2A—melanoma	1.49e-05	0.000197	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTAP—melanoma	1.49e-05	0.000196	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	1.48e-05	0.000195	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD86—melanoma	1.47e-05	0.000194	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—melanoma	1.47e-05	0.000194	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.46e-05	0.000192	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EDN1—melanoma	1.45e-05	0.000192	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.45e-05	0.000192	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTAP—melanoma	1.45e-05	0.000192	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.45e-05	0.000191	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—melanoma	1.43e-05	0.000189	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PRKCA—melanoma	1.42e-05	0.000188	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CSF2—melanoma	1.42e-05	0.000188	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF1—melanoma	1.42e-05	0.000188	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.42e-05	0.000188	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—melanoma	1.41e-05	0.000187	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.41e-05	0.000187	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—melanoma	1.41e-05	0.000187	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ERCC2—melanoma	1.41e-05	0.000186	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—melanoma	1.4e-05	0.000185	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—melanoma	1.4e-05	0.000185	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—E2F1—melanoma	1.39e-05	0.000184	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP17A1—melanoma	1.39e-05	0.000183	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—melanoma	1.38e-05	0.000183	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.38e-05	0.000183	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFRA—melanoma	1.38e-05	0.000182	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.37e-05	0.000181	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRKCA—melanoma	1.36e-05	0.00018	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ITGB3—melanoma	1.36e-05	0.00018	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK3—melanoma	1.35e-05	0.000179	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.34e-05	0.000177	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SPP1—melanoma	1.34e-05	0.000177	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.33e-05	0.000176	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAP2K2—melanoma	1.33e-05	0.000176	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—melanoma	1.33e-05	0.000176	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.33e-05	0.000175	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LUM—melanoma	1.32e-05	0.000175	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PHGDH—melanoma	1.32e-05	0.000175	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—melanoma	1.32e-05	0.000174	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNA11—melanoma	1.31e-05	0.000173	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HPSE—melanoma	1.3e-05	0.000172	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PHGDH—melanoma	1.29e-05	0.000171	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LUM—melanoma	1.29e-05	0.000171	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK1—melanoma	1.29e-05	0.00017	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—melanoma	1.29e-05	0.00017	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	1.28e-05	0.00017	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—FASN—melanoma	1.28e-05	0.000169	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CUBN—melanoma	1.27e-05	0.000168	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—melanoma	1.27e-05	0.000168	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HPSE—melanoma	1.27e-05	0.000167	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—melanoma	1.27e-05	0.000167	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAC1—melanoma	1.26e-05	0.000167	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC5A5—melanoma	1.26e-05	0.000167	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH1—melanoma	1.25e-05	0.000165	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CUBN—melanoma	1.24e-05	0.000164	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BSG—melanoma	1.23e-05	0.000163	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CSPG4—melanoma	1.23e-05	0.000163	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SDHD—melanoma	1.23e-05	0.000163	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—melanoma	1.22e-05	0.000162	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CD44—melanoma	1.22e-05	0.000161	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNAQ—melanoma	1.22e-05	0.000161	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—melanoma	1.21e-05	0.000161	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PRKCA—melanoma	1.21e-05	0.00016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—melanoma	1.21e-05	0.00016	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.2e-05	0.000159	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ERCC2—melanoma	1.2e-05	0.000159	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SDHD—melanoma	1.2e-05	0.000159	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BSG—melanoma	1.2e-05	0.000159	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CSPG4—melanoma	1.2e-05	0.000159	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPAM—melanoma	1.19e-05	0.000158	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.17e-05	0.000154	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1B1—melanoma	1.17e-05	0.000154	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPAM—melanoma	1.16e-05	0.000154	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—melanoma	1.16e-05	0.000153	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.14e-05	0.000151	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FN1—melanoma	1.12e-05	0.000147	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—melanoma	1.11e-05	0.000147	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.11e-05	0.000146	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—melanoma	1.09e-05	0.000144	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.08e-05	0.000143	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.08e-05	0.000143	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—melanoma	1.07e-05	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD80—melanoma	1.07e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—melanoma	1.07e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—melanoma	1.07e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—melanoma	1.07e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—melanoma	1.07e-05	0.000141	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGF—melanoma	1.06e-05	0.000139	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—melanoma	1.03e-05	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.03e-05	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.02e-05	0.000135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—melanoma	1.02e-05	0.000135	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLA2G6—melanoma	1.01e-05	0.000134	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—melanoma	1e-05	0.000133	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.97e-06	0.000132	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLA2G6—melanoma	9.89e-06	0.000131	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—melanoma	9.88e-06	0.000131	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—melanoma	9.79e-06	0.000129	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—melanoma	9.77e-06	0.000129	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK1—melanoma	9.73e-06	0.000129	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—melanoma	9.72e-06	0.000128	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—melanoma	9.67e-06	0.000128	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—melanoma	9.61e-06	0.000127	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—melanoma	9.5e-06	0.000126	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAP2K1—melanoma	9.45e-06	0.000125	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	9.41e-06	0.000124	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—melanoma	9.38e-06	0.000124	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—melanoma	9.29e-06	0.000123	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—melanoma	9.19e-06	0.000121	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—melanoma	9.12e-06	0.00012	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—VCAN—melanoma	9.1e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.1e-06	0.00012	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF2—melanoma	8.98e-06	0.000119	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—VCAN—melanoma	8.89e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PRKCA—melanoma	8.85e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ERCC2—melanoma	8.77e-06	0.000116	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.62e-06	0.000114	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—melanoma	8.53e-06	0.000113	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—melanoma	8.46e-06	0.000112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—melanoma	8.44e-06	0.000112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—melanoma	8.41e-06	0.000111	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—melanoma	8.35e-06	0.00011	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.32e-06	0.00011	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—melanoma	8.29e-06	0.00011	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—melanoma	8.25e-06	0.000109	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—melanoma	8.18e-06	0.000108	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—melanoma	7.86e-06	0.000104	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—melanoma	7.81e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.69e-06	0.000102	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP17A1—melanoma	7.68e-06	0.000102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—melanoma	7.68e-06	0.000101	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—melanoma	7.59e-06	0.0001	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.58e-06	0.0001	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—melanoma	7.52e-06	9.94e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—melanoma	7.51e-06	9.93e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP17A1—melanoma	7.5e-06	9.91e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	7.48e-06	9.88e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—melanoma	7.47e-06	9.88e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—melanoma	7.37e-06	9.75e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—melanoma	7.32e-06	9.68e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—melanoma	7.28e-06	9.62e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNA11—melanoma	7.25e-06	9.59e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—melanoma	7.25e-06	9.58e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—melanoma	7.22e-06	9.53e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—melanoma	7.11e-06	9.39e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FASN—melanoma	7.1e-06	9.38e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—melanoma	7.08e-06	9.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNA11—melanoma	7.08e-06	9.36e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—melanoma	7.07e-06	9.34e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKB1—melanoma	7.03e-06	9.29e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—melanoma	6.98e-06	9.23e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.94e-06	9.17e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FASN—melanoma	6.93e-06	9.16e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—melanoma	6.93e-06	9.16e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—melanoma	6.91e-06	9.14e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—melanoma	6.89e-06	9.11e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—melanoma	6.82e-06	9.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CD44—melanoma	6.74e-06	8.91e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNAQ—melanoma	6.74e-06	8.91e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—melanoma	6.72e-06	8.89e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—melanoma	6.69e-06	8.84e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.6e-06	8.73e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CD44—melanoma	6.58e-06	8.7e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNAQ—melanoma	6.58e-06	8.7e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.54e-06	8.65e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1B1—melanoma	6.47e-06	8.54e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—melanoma	6.38e-06	8.43e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—melanoma	6.32e-06	8.35e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1B1—melanoma	6.31e-06	8.34e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—melanoma	6.31e-06	8.33e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—melanoma	6.29e-06	8.31e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—melanoma	6.09e-06	8.05e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—melanoma	6.04e-06	7.98e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—melanoma	6.01e-06	7.95e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—melanoma	5.87e-06	7.76e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK1—melanoma	5.75e-06	7.59e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—melanoma	5.74e-06	7.59e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.71e-06	7.54e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—melanoma	5.43e-06	7.17e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—melanoma	5.32e-06	7.04e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—melanoma	5.31e-06	7.02e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—melanoma	5.26e-06	6.95e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—melanoma	5.2e-06	6.87e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—melanoma	4.99e-06	6.59e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PRKCA—melanoma	4.9e-06	6.48e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ERCC2—melanoma	4.86e-06	6.42e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—melanoma	4.82e-06	6.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PRKCA—melanoma	4.78e-06	6.32e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ERCC2—melanoma	4.74e-06	6.27e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—melanoma	4.66e-06	6.16e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—melanoma	4.61e-06	6.1e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—melanoma	4.59e-06	6.06e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—melanoma	4.44e-06	5.87e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—melanoma	4.41e-06	5.83e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—melanoma	4.25e-06	5.62e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—melanoma	4.07e-06	5.38e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.03e-06	5.32e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—melanoma	3.84e-06	5.07e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—melanoma	3.75e-06	4.95e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—melanoma	3.7e-06	4.9e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—melanoma	3.63e-06	4.79e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—melanoma	3.62e-06	4.78e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—melanoma	3.37e-06	4.46e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—melanoma	3.33e-06	4.4e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—melanoma	3.29e-06	4.35e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—melanoma	3.25e-06	4.3e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—melanoma	3.24e-06	4.28e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—melanoma	2.94e-06	3.89e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—melanoma	2.91e-06	3.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—melanoma	2.87e-06	3.79e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—melanoma	2.84e-06	3.76e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—melanoma	2.64e-06	3.49e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—melanoma	2.54e-06	3.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—melanoma	2.48e-06	3.28e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—melanoma	1.79e-06	2.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—melanoma	1.75e-06	2.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—melanoma	1.46e-06	1.94e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—melanoma	1.43e-06	1.89e-05	CbGpPWpGaD
